PIPEHAWK PLC

Regulatory Filings • Dec 8, 2020

National Storage Mechanism | Additional information

RNS Number : 8275H

PipeHawk PLC

08 December 2020

Reach

8 December 2020

PipeHawk plc

("PipeHawk" or the "Company")

Major contract award to QM Systems

PipeHawk is pleased to announce that its wholly owned subsidiary, QM Systems Limited, has been awarded a contract to provide a 'state of the art' manufacturing facility to Marlux Medical Limited ("Marlux Medical") for the manufacture of specialist medical products for health services. 

Marlux Medical is part of the Summit Medical group and is one of the UK's leading medical manufacturers of medical products.  The project, which is worth circa £800,000, will start immediately and is due for completion in September 2021. The facility will increase throughput capability as well as an increased variant capability allowing Marlux to expand its existing client base and volume capacity.

Gordon Watt, Chairman of PipeHawk, commented: "This is excellent news and demonstrates how the diverse nature of the QM Systems portfolio of partners and unique skill set has enabled it to navigate the difficult conditions experienced in light of the current COVID-19 crisis, and to continue to provide innovation driven manufacturing solutions. QM Systems is proud to be the partner of choice for Marlux and we look forward to working closely together going forward."

Enquiries:

PipeHawk Plc Gordon Watt (Chairman)	Tel. No. 01252 338 959
Allenby Capital (Nomad and Broker) David Worlidge/Asha Chotai	Tel. No. 020 3328 5656

Notes to Editors 

For further information on the Company and its subsidiaries, please visit:  www.pipehawk.com

About RNS Reach announcements

This is an RNS Reach announcement. RNS Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRABLBDDIUGDGGR